K072371

Substantially Equivalent

ODYSSEY WORKSTATION

Applicant: Stereotaxis, Inc.
Product code: DXX
Advisory panel: Cardiovascular
Date received: 2007-08-23
Decision date: 2007-11-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St. Louis, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.